The Trump administration's December 2025 executive order accelerated federal cannabis rescheduling efforts under the Controlled Substances Act, prompting the Justice Department and DEA to move state-licensed medical marijuana and FDA-approved products to Schedule III effective April 28, 2026. An expedited administrative hearing on broader rescheduling of all marijuana from Schedule I to III ran from June 29 to July 15, 2026, following withdrawal of prior proceedings. Legal challenges to the partial rescheduling consolidated in the D.C. Circuit Court of Appeals add procedural uncertainty, while trader odds on timelines such as September or December 2026 reflect the time needed for final rulemaking, potential appeals, and any further agency actions.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日$791,969 Vol.
2026/03/31
9月30日
14%
12月31日
28%
$791,969 Vol.
9月30日
$0 Vol.
14%
12月31日
$182,399 Vol.
28%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), between market creation and September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The Trump administration's December 2025 executive order accelerated federal cannabis rescheduling efforts under the Controlled Substances Act, prompting the Justice Department and DEA to move state-licensed medical marijuana and FDA-approved products to Schedule III effective April 28, 2026. An expedited administrative hearing on broader rescheduling of all marijuana from Schedule I to III ran from June 29 to July 15, 2026, following withdrawal of prior proceedings. Legal challenges to the partial rescheduling consolidated in the D.C. Circuit Court of Appeals add procedural uncertainty, while trader odds on timelines such as September or December 2026 reflect the time needed for final rulemaking, potential appeals, and any further agency actions.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
マーケット開始日： Feb 7, 2026, 5:04 PM ET
音量
$791,969終了日
2026/03/31マーケット開始日
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), between market creation and September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The Trump administration's December 2025 executive order accelerated federal cannabis rescheduling efforts under the Controlled Substances Act, prompting the Justice Department and DEA to move state-licensed medical marijuana and FDA-approved products to Schedule III effective April 28, 2026. An expedited administrative hearing on broader rescheduling of all marijuana from Schedule I to III ran from June 29 to July 15, 2026, following withdrawal of prior proceedings. Legal challenges to the partial rescheduling consolidated in the D.C. Circuit Court of Appeals add procedural uncertainty, while trader odds on timelines such as September or December 2026 reflect the time needed for final rulemaking, potential appeals, and any further agency actions.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
音量
$791,969終了日
2026/03/31マーケット開始日
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...The Trump administration's December 2025 executive order accelerated federal cannabis rescheduling efforts under the Controlled Substances Act, prompting the Justice Department and DEA to move state-licensed medical marijuana and FDA-approved products to Schedule III effective April 28, 2026. An expedited administrative hearing on broader rescheduling of all marijuana from Schedule I to III ran from June 29 to July 15, 2026, following withdrawal of prior proceedings. Legal challenges to the partial rescheduling consolidated in the D.C. Circuit Court of Appeals add procedural uncertainty, while trader odds on timelines such as September or December 2026 reflect the time needed for final rulemaking, potential appeals, and any further agency actions.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問